Literature DB >> 22439019

Prenatal screening of Cystic Fibrosis: a single centre experience.

Domenico Bizzoco1, Alvaro Mesoraca, Antonella Cima, Monica Sarti, Gianluca Di Giacomo, Giovanna Scerra, Maria Antonietta Barone, Manuela Di Natale, Ivan Gabrielli, Caterina Tamburino, Claudia Scargiali, Cristina Ernandez, Maria Pia D'Aleo, Michele Todini, Rita Pompili, Luisa Mobili, Lucia Mangiafico, Ornella Carcioppolo, Claudio Coco, Pietro Cignini, Laura D'Emidio, Alessandra Girgenti, Cristiana Brizzi, Alessandro Cavaliere, Claudio Giorlandino.   

Abstract

OBJECTIVE: The gene responsible for the pathogenesis of cystic fibrosis has been known for over 15 years and represent the most common autosomal recessive disease in the european population. We aimed to investigate the incidence of this condition during fetal life.
METHODS: In the past 10 years we examined in our centre 25393 fetuses of women underwent to amniocentesis. We carried out the examination of the most frequent mutations which enable, according to the literature data, the identification of almost 80% of the affected alleles. RESULT: We identified 922 heterozygous and 9 homozygous for the mutation. The frequency of heterozygousin the examined sample was 1/27,5 while that of the affected was 1/2821.
CONCLUSION: We encourage new thoughts regarding the diagnostic validity of the most frequent panel of mutations among the italian population in order to exclude never encountered mutations and the insertion of other more significant mutations.

Entities:  

Keywords:  cystic fibrosis; prenatal diagnosis; screening tests

Year:  2008        PMID: 22439019      PMCID: PMC3279087     

Source DB:  PubMed          Journal:  J Prenat Med        ISSN: 1971-3282


  38 in total

Review 1.  The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.

Authors:  B J Rosenstein; G R Cutting
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

2.  Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution.

Authors:  S Rendine; F Calafell; N Cappello; R Gagliardini; G Caramia; N Rigillo; M Silvetti; M Zanda; A Miano; F Battistini; L Marianelli; G Taccetti; M C Diana; L Romano; C Romano; A Giunta; R Padoan; A Pianaroli; V Raia; G De Ritis; A Battistini; G Grzincich; L Japichino; F Pardo; A Piazza
Journal:  Ann Hum Genet       Date:  1997-09       Impact factor: 1.670

3.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

4.  Spectrum of mutations in the CFTR gene in cystic fibrosis patients of Spanish ancestry.

Authors:  M J Alonso; D Heine-Suñer; M Calvo; J Rosell; J Giménez; M D Ramos; J J Telleria; A Palacio; X Estivill; T Casals
Journal:  Ann Hum Genet       Date:  2007-03       Impact factor: 1.670

5.  DHPLC screening of cystic fibrosis gene mutations.

Authors:  Metka Ravnik-Glavac; Andrew Atkinson; Damjan Glavac; Michael Dean
Journal:  Hum Mutat       Date:  2002-04       Impact factor: 4.878

6.  Correlation between genotype and phenotype in patients with cystic fibrosis.

Authors: 
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

7.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

Review 8.  Nonclassic cystic fibrosis and CFTR-related diseases.

Authors:  Michael P Boyle
Journal:  Curr Opin Pulm Med       Date:  2003-11       Impact factor: 3.155

9.  Standards and guidelines for CFTR mutation testing.

Authors:  Carolyn Sue Richards; Linda A Bradley; Jean Amos; Bernice Allitto; Wayne W Grody; Anne Maddalena; Matthew J McGinnis; Thomas W Prior; Bradley W Popovich; Michael S Watson; Glenn E Palomaki
Journal:  Genet Med       Date:  2002 Sep-Oct       Impact factor: 8.822

10.  Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy.

Authors:  Maria Rosaria D'Apice; Stefano Gambardella; Mario Bengala; Silvia Russo; Anna Maria Nardone; Vincenzina Lucidi; Federica Sangiuolo; Giuseppe Novelli
Journal:  BMC Med Genet       Date:  2004-04-14       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.